Floatz logo

Cytosin-Arabinosid

Primary Mediastinal Large B-Cell Lymphoma

City of Hope Medical CenterPhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Primary Mediastinal Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
University of Washington
Phase 4BBB
PREDNISONE TABLETS
University of Washington
Phase 3BB
Eloxatin
City of Hope Medical Center
Phase 2BB
Glofitamab
The Lymphoma Academic Research Organisation
Phase 2BB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
National Research Center for Hematology, Russia
Phase 3BB

View all 11 →

Same molecule, other indications

Cytosin-Arabinosid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →